AI in Precision Medicine Market Size Share Growth and Report 2024-2031

Market Overview:

The global AI in precision medicine market is projected to reach at a high CAGR from 2024 to 2031. The market is expanding rapidly due to AI's potential to revolutionize healthcare by improving patient outcomes and reducing costs. Key technologies in this market include deep learning, querying methods, natural language processing, and context-aware processing, which enable personalized treatment plans by analyzing each patient's unique genetic and disease characteristics.

Market Dynamics:

The increasing incidence of cancer significantly drives the market for AI in precision medicine. The World Health Organization reported that cancer was responsible for 10 million deaths globally in 2020. The demand for AI-driven precision healthcare solutions is rising to meet the need for more accurate and personalized cancer treatments.

For example, the National Cancer Institute estimated that 17.35 million new cancer cases were diagnosed in the U.S. in 2020, leading to 609,640 deaths. Globally, there were 18 million new cases and 9.5 million deaths from cancer. By 2030, the U.S. is projected to see 23.6 million new cases, with the global number increasing by 70% by 2035. Strategic initiatives by major players, such as Google's collaboration with iCAD, Inc. for mammography in November 2022, aim to improve cancer detection and risk assessment.

The high costs associated with precision medicine and AI technologies, along with data privacy and security concerns, are significant barriers to market growth. The high cost of implementing AI technologies, along with stringent regulatory and reimbursement requirements, limited awareness, and interpretability issues, also hamper market expansion.

Download Sample: https://www.datamintelligence.com/download-sample/ai-in-precision-medicine-market

Segment Analysis:

The deep learning segment accounted for approximately 43.3% of the AI in precision medicine market share and is expected to dominate over the forecast period. The growth of this segment is driven by advancements in data center capabilities, increased processing power, and the ability to perform autonomous tasks. Deep learning algorithms can integrate and model diverse patient data over time and across multiple modalities, leading to improved predictive accuracy and personalized treatment recommendations.
The market is segmented into hardware, software, and services. The software segment is expected to grow significantly due to advancements in AI software platforms that facilitate personalized medicine.

Applications of AI in precision medicine include oncology, cardiology, neurology, respiratory, and others. Oncology holds a significant market share due to the rising prevalence of cancer and the need for precise and individualized treatments.

North America is projected to hold approximately 41.2% of the global market share, driven by the presence of major industry players, strong healthcare infrastructure, and significant investment in AI and precision medicine research. The region's growth is also supported by collaborations and strategic initiatives, such as Certara, Inc.'s partnership with Memorial Sloan Kettering Cancer Centre to develop a bio-simulation platform for CAR-T cell therapy in July 2022.

Geographical Analysis:

North America leads the market due to the high prevalence of cancer, substantial healthcare spending, and active participation of major players like Google, IBM Watson, and NVIDIA in AI innovation. The region's commitment to personalized care is evident in initiatives like the establishment of the Precision Medicine Institute by Children's Colorado in July 2023.

To access the complete report: https://www.datamintelligence.com/research-report/ai-in-precision-medicine-market

Competitive Landscape:

The AI in precision medicine market is highly competitive, with key players including IBM Corporation, Microsoft Corporation, AstraZeneca, Sanofi, GE Healthcare, Intel Corporation, NVIDIA Corporation, Alphabet Inc, BioXcel Therapeutics Inc, and Enlitic Inc. These companies are at the forefront of developing and implementing AI solutions to enhance precision medicine and improve patient outcomes.

Related Reports:

Medication Management Systems Market: https://www.datamintelligence.com/research-report/medication-management-systems-market

Oncology EMR Software Market: https://www.datamintelligence.com/research-report/oncology-emr-software-market

Computer Aided Detection (CAD) Market: https://www.datamintelligence.com/research-report/computer-aided-detection-market

Acute Renal Failure Therapeutics Market: https://www.datamintelligence.com/research-report/acute-renal-failure-therapeutics-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: DataMIntelligence

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.